Clinical Trial Update: A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating telitacicept for ocular myasthenia gravis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Myasthenia Gravis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Myasthenia Gravis, Ocular | Phase 3 | Status: RECRUITING